Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan-From the CREDO-Kyoto Registry Cohort-2 and Cohort-3

被引：2

作者：

Natsuaki, Masahiro ^{[1
]}

Morimoto, Takeshi ^{[2
]}

Shiomi, Hiroki ^{[3
]}

Yamamoto, Ko ^{[3
]}

Yamaji, Kyohei ^{[4
]}

Watanabe, Hirotoshi ^{[3
]}

Uegaito, Takashi ^{[5
]}

Matsuda, Mitsuo ^{[5
]}

Tamura, Toshihiro ^{[6
]}

Taniguchi, Ryoji ^{[7
]}

Inoko, Moriaki ^{[8
]}

Mabuchi, Hiroshi ^{[9
]}

Takeda, Teruki ^{[9
]}

Domei, Takenori ^{[4
]}

Shirotani, Manabu ^{[10
]}

Ehara, Natsuhiko ^{[11
]}

Eizawa, Hiroshi ^{[12
]}

Ishii, Katsuhisa ^{[13
]}

Tanaka, Masaru ^{[14
]}

Inada, Tsukasa ^{[14
]}

Onodera, Tomoya ^{[15
]}

Nawada, Ryuzo ^{[15
]}

Shinoda, Eiji ^{[16
]}

Yamada, Miho ^{[16
]}

Yamamoto, Takashi ^{[17
]}

Sakai, Hiroshi ^{[17
]}

Toyofuku, Mamoru ^{[18
]}

Tamura, Takashi ^{[18
]}

Takahashi, Mamoru ^{[19
]}

Tada, Tomohisa ^{[20
]}

Sakamoto, Hiroki ^{[20
]}

Tada, Takeshi ^{[21
]}

Kaneda, Kazuhisa ^{[3
]}

Miki, Shinji ^{[22
]}

Aoyama, Takeshi ^{[23
]}

Suwa, Satoru ^{[24
]}

Sato, Yukihito ^{[7
]}

Ando, Kenji ^{[4
]}

Furukawa, Yutaka ^{[11
]}

Nakagawa, Yoshihisa ^{[17
]}

Kadota, Kazushige ^{[21
]}

Kimura, Takeshi ^{[3
]}

机构：

[1] Saga Univ, Dept Cardiovasc Med, Saga, Japan

[2] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo, Japan

[3] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan

[4] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka, Japan

[5] Kishiwada City Hosp, Dept Cardiol, Kishiwada, Japan

[6] Tenri Hosp, Dept Cardiol, Tenri, Nara, Japan

[7] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Cardiol, Amagasaki, Hyogo, Japan

[8] Kitano Hosp, Dept Cardiol, Osaka, Japan

[9] Koto Mem Hosp, Dept Cardiol, Higashiomi, Japan

[10] Kindai Univ, Dept Cardiol, Nara Hosp, Ikoma, Japan

[11] Kobe City Med Ctr, Dept Cardiovasc Med, Gen Hosp, Kobe, Hyogo, Japan

[12] Kobe City Nishi Kobe Med Ctr, Dept Cardiovasc Med, Kobe, Hyogo, Japan

[13] Kansai Denryoku Hosp, Dept Cardiol, Osaka, Japan

[14] Osaka Red Cross Hosp, Dept Cardiol, Osaka, Japan

[15] Shizuoka City Shizuoka Hosp, Dept Cardiol, Shizuoka, Japan

[16] Hamamatsu Rosai Hosp, Dept Cardiol, Hamamatsu, Shizuoka, Japan

[17] Shiga Univ Med Sci Hosp, Dept Cardiol, Otsu, Shiga, Japan

[18] Japanese Red Cross Wakayama Med Ctr, Dept Cardiol, Wakayama, Japan

[19] Shimabara Hosp, Dept Cardiol, Kyoto, Japan

[20] Shizuoka Prefectural Gen Hosp, Dept Cardiol, Shizuoka, Japan

[21] Kurashiki Cent Hosp, Dept Cardiol, Kurashiki, Okayama, Japan

[22] Mitsubishi Kyoto Hosp, Dept Cardiol, Kyoto, Japan

[23] Shimada Municipal Hosp, Div Cardiol, Shimada, Japan

[24] Juntendo Univ, Dept Cardiol, Shizuoka Hosp, Izunokuni, Japan

来源：

CIRCULATION JOURNAL | 2022年 / 86卷 / 05期

关键词：

  Coronary artery disease; High bleeding risk; Percutaneous coronary intervention; DUAL ANTIPLATELET THERAPY; BARE-METAL; CARDIOVASCULAR EVENTS; STENT; CLOPIDOGREL; MONOTHERAPY; TICAGRELOR; TRENDS;

D O I：

10.1253/circj.CJ-21-0526

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Optimal intensity is unclear for P2Y12 receptor blocker therapy after percutaneous coronary intervention (PCI) in realMethods and Results: From the CREDO-Kyoto Registry, the current study population consisted of 25,419 patients (Cohort-2: n=12,161 and Cohort-3: n=13,258) who underwent their first PCI. P2Y12 receptor blocker therapies were reduced dose of ticlopidine (200 mg/day), and global dose of clopidogrel (75 mg/day) in 87.7% and 94.8% of patients in Cohort-2 and Cohort-3, respectively. Cumulative 3-year incidence of GUSTO moderate/severe bleeding was significantly higher in Cohort-3 than in Cohort-2 (12.1% and 9.0%, P<0.0001). After adjusting 17 demographic factors and 9 management factors potentially related to the bleeding events other than the type of P2Y12 receptor blocker, the higher bleeding risk in Cohort-3 relative to Cohort-2 remained significant (hazard ratio (HR): 1.52 95% confidence interval (CI) 1.37-1.68, P<0.0001). Cohort-3 compared with Cohort-2 was not associated with lower adjusted risk for myocardial infarction/ischemic stroke (HR: 0.96, 95% CI: 0.87-1.06, P=0.44). Conclusions: In this historical comparative study, Cohort-3 compared with Cohort-2 was associated with excess bleeding risk, which might be at least partly explained by the difference in P2Y12 receptor blockers.

引用

页码：748 / +

页数：30

共 50 条

[41] Impact of Left Ventricular Diastolic Dysfunction on Long-Term Outcomes Following Coronary Artery Bypass Grafting: 5-Year Outcomes of the CREDO-Kyoto CABG Registry Cohort-2
Marui, Akira
Nishiwaki, Noboru
Komiya, Tatsuhiko
Hanyu, Michiya
Tanaka, Shiro
Kimura, Takeshi
Sakata, Ryuzo
CIRCULATION, 2014, 130
[42] Dual antiplatelet therapy discontinuation after coronary stenting and the risk of short-term cardiac adverse events: observation from CREDO-Kyoto Cohort-2
Watanabe, H.
Morimoto, T.
Natsuaki, M.
Shiomi, H.
Furukawa, Y.
Nakagawa, Y.
Kadota, K.
Ando, K.
Kimura, T.
EUROPEAN HEART JOURNAL, 2014, 35 : 25 - 25
[43] Percutaneous coronary intervention using new-generation drug-eluting stents versus coronary arterial bypass grafting in stable patients with multi-vessel coronary artery disease: From the CREDO-Kyoto PCI/CABG registry Cohort-3
Watanabe, Hiroki
Yamamoto, Ko
Shiomi, Hiroki
Morimoto, Takeshi
Kato, Eri
Matsumura, Yukiko
Nakatsuma, Kenji
Takeji, Yasuaki
Yaku, Hidenori
Yamamoto, Erika
Yamashita, Yugo
Yoshikawa, Yusuke
Fuki, Masayuki
Yamaji, Kyohei
Ehara, Natsuhiko
Sakamoto, Hiroki
Imada, Kazuaki
Tada, Takeshi
Taniguchi, Ryoji
Nishikawa, Ryusuke
Tada, Tomohisa
Uegaito, Takashi
Ogawa, Tatsuya
Yamada, Miho
Takeda, Teruki
Eizawa, Hiroshi
Tamura, Nobushige
Tambara, Keiichi
Suwa, Satoru
Shirotani, Manabu
Tamura, Toshihiro
Inoko, Moriaki
Nishizawa, Junichiro
Natsuaki, Masahiro
Sakai, Hiroshi
Yamamoto, Takashi
Kanemitsu, Naoki
Ohno, Nobuhisa
Ishii, Katsuhisa
Marui, Akira
Tsuneyoshi, Hiroshi
Terai, Yasuhiko
Nakayama, Shogo
Yamazaki, Kazuhiro
Takahashi, Mamoru
Tamura, Takashi
Esaki, Jiro
Miki, Shinji
Onodera, Tomoya
Mabuchi, Hiroshi
PLOS ONE, 2022, 17 (09):
[44] Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2)
Marui, Akira
Nishiwaki, Noboru
Komiya, Tatsuhiko
Hanyu, Michiya
Tanaka, Shiro
Kimura, Takeshi
Sakata, Ryuzo
AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (04): : 580 - 586
[45] Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3)
Yamamoto, Ko
Shiomi, Hiroki
Morimoto, Takeshi
Kadota, Kazushige
Tada, Tomohisa
Takeji, Yasuaki
Matsumura-Nakano, Yukiko
Yoshikawa, Yusuke
Imada, Kazuaki
Domei, Takenori
Kaneda, Kazuhisa
Taniguchi, Ryoji
Ehara, Natsuhiko
Nawada, Ryuzo
Natsuaki, Masahiro
Yamaji, Kyohei
Toyofuku, Mamoru
Kanemitsu, Naoki
Shinoda, Eiji
Suwa, Satoru
Iwakura, Atsushi
Tamura, Toshihiro
Soga, Yoshiharu
Inada, Tsukasa
Matsuda, Mitsuo
Koyama, Tadaaki
Aoyama, Takeshi
Sato, Yukihito
Furukawa, Yutaka
Ando, Kenji
Yamazaki, Fumio
Komiya, Tatsuhiko
Minatoya, Kenji
Nakagawa, Yoshihisa
Kimura, Takeshi
AMERICAN JOURNAL OF CARDIOLOGY, 2021, 145 : 47 - 57
[46] Optimal Coronary Revascularization in Patients With Unstable Angina or Non-ST-Elevation Myocardial Infarction: 5-Year Outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2
Marui, Akira
Kimura, Takeshi
Nishiwaki, Noboru
Mitsudo, Kazuaki
Komiya, Tatsuhiko
Hanyu, Michiya
Shiomi, Hiroki
Tanaka, Shiro
Sakata, Ryuzo
CIRCULATION, 2014, 130
[47] Short versus prolonged dual antiplatelet therapy duration after bare-metal stent implantation: 2-month landmark analysis from the CREDO-Kyoto registry cohort-2
Natsuaki M.
Morimoto T.
Furukawa Y.
Nakagawa Y.
Kadota K.
Ando K.
Shiomi H.
Toyota T.
Watanabe H.
Ono K.
Shizuta S.
Tamura T.
Inoko M.
Inada T.
Shirotani M.
Matsuda M.
Aoyama T.
Onodera T.
Suwa S.
Takeda T.
Inoue K.
Kimura T.
Cardiovascular Intervention and Therapeutics, 2018, 33 (1) : 23 - 34
[48] Short versus prolonged dual antiplatelet therapy duration after bare-metal stent implantation: 2-month landmark analysis from the Credo-Kyoto registry cohort-2
Natsuaki, M.
Morimoto, T.
Fukukawa, Y.
Kimura, T.
EUROPEAN HEART JOURNAL, 2016, 37 : 634 - 635
[49] Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease-5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2-
Shiomi, Hiroki
Morimoto, Takeshi
Furukawa, Yutaka
Nakagawa, Yoshihisa
Sakata, Ryuzo
Okabayashi, Hitoshi
Hanyu, Michiya
Shimamoto, Mitsuomi
Nishiwaki, Noboru
Komiya, Tatsuhiko
Kimura, Takeshi
CIRCULATION JOURNAL, 2015, 79 (06) : 1282 - +
[50] Duration of Dual Antiplatelet Therapy and Long-Term Clinical Outcome After Coronary Drug-Eluting Stent Implantation Landmark Analyses From the CREDO-Kyoto PCI/CABG Registry Cohort-2
Tada, Tomohisa
Natsuaki, Masahiro
Morimoto, Takeshi
Furukawa, Yutaka
Nakagawa, Yoshihisa
Byrne, Robert A.
Kastrati, Adnan
Kadota, Kazushige
Iwabuchi, Masashi
Shizuta, Satoshi
Tazaki, Junichi
Shiomi, Hiroki
Abe, Mitsuru
Ehara, Natsuhiko
Mizoguchi, Tetsu
Mitsuoka, Hirokazu
Inada, Tsukasa
Araki, Makoto
Kaburagi, Satoshi
Taniguchi, Ryoji
Eizawa, Hiroshi
Nakano, Akira
Suwa, Satoru
Takizawa, Akinori
Nohara, Ryuji
Fujiwara, Hisayoshi
Mitsudo, Kazuaki
Nobuyoshi, Masakiyo
Kita, Toru
Kimura, Takeshi
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (03) : 381 - 391

← 1 2 3 4 5 →